October 2026 Cannabis Stock Outlook: 3 Companies Facing Major Changes
The cannabis industry continues to attract investors searching for opportunities in the expanding marijuana market. However, October 2026 presents a challenging environment for many publicly traded cannabis companies. Rising operating expenses, intense competition, and uncertain federal regulations continue to affect the industry’s overall performance. Meanwhile, several cannabis operators are adjusting their business strategies to strengthen their financial positions. Some companies are exploring new markets, while others are cutting costs and restructuring operations. Additionally, investors are paying closer attention to profitability, cash flow, and long-term financial stability. Federal cannabis reform remains another important factor influencing investor sentiment. Although regulatory changes could create opportunities, their timing and potential benefits remain uncertain. Consequently, marijuana stocks continue experiencing volatility as investors evaluate the industry’s future. Despite these challenges, established cannabis companies maintain significant retail networks and recognizable brands. Their ability to improve financial performance could influence investor interest during the final months of 2026.
Cannabis Industry Faces New Opportunities
As October progresses, investors are monitoring several marijuana companies with different growth prospects and financial challenges. Planet 13 Holdings continues focusing on improving operations and strengthening its position in Florida’s medical cannabis market. Meanwhile, Curaleaf Holdings maintains one of the industry’s largest retail networks and continues pursuing international opportunities. AYR Wellness presents a different situation following substantial financial difficulties and creditor-led restructuring. Although these companies operate within the same industry, their investment risks differ considerably. Furthermore, changing consumer demand and competitive pricing continue to influence cannabis sales across major American markets. Companies with stronger balance sheets may have greater flexibility to navigate these challenges. However, businesses carrying significant debt could face additional financial pressure. Investors should carefully review quarterly earnings, operating expenses, and available cash before considering cannabis investments. With these factors in mind, three marijuana stocks deserve attention during October 2026: Planet 13 Holdings, AYR Wellness, and Curaleaf Holdings.
[Read More] Cannabis Rescheduling in 2026: 3 Marijuana Stocks Worth Watching
3 Marijuana Stocks to Watch as Cannabis Companies Focus on Profitability
- Planet 13 Holdings (OTC: PLNH)
- AYR Wellness (OTC: AYRWF)
- Curaleaf Holdings (OTC: CURLF)
Planet 13 Holdings (PLNH)
Planet 13 Holdings is a vertically integrated cannabis company headquartered in Las Vegas, Nevada. The company operates cultivation, manufacturing, and retail businesses across several American cannabis markets. Its flagship Las Vegas SuperStore remains one of the country’s most recognizable cannabis retail destinations. However, Florida is the company’s largest market by dispensary count. Planet 13 operates approximately 33 medical marijuana dispensaries throughout Florida following its acquisition of VidaCann.
Additionally, the company maintains two retail locations in Nevada and one in Illinois. This brings its retail footprint to approximately 36 dispensaries across three states. Furthermore, Planet 13 offers several cannabis products, including flower, concentrates, edibles, and other manufactured products. Its business strategy increasingly emphasizes operational efficiency and improving existing retail locations. Meanwhile, Florida remains an important opportunity because of its established medical marijuana market. As a result, Planet 13 continues to attract investors interested in smaller cannabis operators with recognizable brands.
Latest Performance
Planet 13 reported second-quarter 2026 revenue of about $22.9 million, down from $26.9 million the previous year. This represented a revenue decline of approximately 14.9%. However, quarterly revenue rose 8.4% from the preceding quarter. Additionally, Florida revenue rose 17.1% sequentially, reflecting stronger sales in the company’s largest retail market. Gross profit reached approximately $12.3 million, compared with $11.7 million one year earlier. Meanwhile, gross margins improved to 53.9%, up from 43.4%. Operating expenses also fell about 22.9%, reflecting management’s continued focus on cost reduction. Furthermore, the company reported a net loss of approximately $5.6 million, improving from a $13.3 million loss. Adjusted EBITDA improved to negative $500,000, compared with negative $2.4 million previously. Despite these improvements, profitability remains an important challenge. Additionally, the proposed Vireo Growth acquisition creates uncertainty regarding Planet 13’s future ownership structure. Investors should monitor transaction developments alongside improving financial results.
[Read More] Cannabis Stocks in 2027: New Markets, Reform And Investment Risks
AYR Wellness (AYRWF)
AYR Wellness established itself as a multistate cannabis operator with cultivation, manufacturing, and retail operations across several American markets. The company developed a significant presence in Florida, Pennsylvania, Massachusetts, New Jersey, Nevada, Ohio, and Virginia. Florida represented its largest retail market, with approximately 67 dispensaries listed under the AYR brand. Additionally, the company developed recognizable cannabis brands, including Kynd, Haze, and Later Days. Its vertically integrated business model originally focused on controlling production and retail distribution.
However, financial difficulties eventually forced substantial changes to its operating structure. During 2026, AYR began transferring major operating assets to Arboretum, an entity established by senior secured creditors. Operations in Florida, New Jersey, and Nevada transferred in June. Meanwhile, the original corporate entity continued proceedings involving creditor protection and liquidation. Consequently, investors should distinguish between dispensaries operating under the AYR name and assets belonging to public shareholders. This distinction creates significant investment uncertainty.
Latest Performance
AYR Wellness faced substantial financial pressure following years of operating losses, significant borrowing, and increasing interest expenses. By early 2025, the company reportedly carried approximately $410 million in debt. Meanwhile, quarterly interest obligations approached $20 million, placing considerable pressure on available cash. These challenges eventually contributed to creditor-led restructuring proceedings. During April 2026, the restructuring included a $275 million senior secured financing facility supporting Arboretum. Additionally, the financing carried a 13% annual interest rate.
However, this funding supported the successor business rather than restoring ownership interests for existing AYR shareholders. The original company also lacked comparable second-quarter 2026 operating results following its restructuring. Consequently, investors cannot evaluate AYRWF using traditional quarterly financial comparisons. Furthermore, the planned corporate wind-down creates substantial uncertainty regarding potential shareholder recovery. Although AYR’s former retail network remains significant, the original public company’s financial position is highly distressed. Therefore, AYRWF represents an exceptionally speculative marijuana security during October 2026.
[Read More] Marijuana Stocks Expand Beyond Traditional Cannabis Companies
Curaleaf Holdings (CURLF)
Curaleaf Holdings is one of the largest cannabis companies operating throughout the United States. The company maintains extensive cultivation, manufacturing, wholesale, and retail operations across several established marijuana markets. Florida represents its largest American retail presence, with approximately 75 dispensaries operating by August 2026. Additionally, Curaleaf reported approximately 176 owned and managed dispensaries across 14 American states. Its wholesale distribution network also serves more than 1,300 partner accounts.
Furthermore, Curaleaf maintains an expanding international presence through medical cannabis operations in European markets. Germany and the United Kingdom remain important components of its international growth strategy. The company offers numerous cannabis products, including flower, concentrates, edibles, and medical marijuana formulations. Meanwhile, Curaleaf continues expanding its premium product portfolio through established brands. Its diversified operations provide exposure to multiple cannabis markets and customer segments. Consequently, CURLF remains a closely watched marijuana stock among investors following large American cannabis operators.
Latest Performance
Curaleaf reported second-quarter 2026 revenue of about $664.3 million, up 8% from the previous year. The company’s performance reflected continued sales growth and contributions from its expanding operations. Gross profit reached approximately $327.2 million, producing a gross margin near 49%. Meanwhile, adjusted EBITDA totaled approximately $133.5 million, representing a margin of 20.1%. Additionally, Curaleaf reported approximately $82.6 million in net income attributable to shareholders from continuing operations. The company continued expanding its Florida dispensary network while strengthening its American retail operations. Furthermore, Curaleaf completed its acquisition of the remaining ownership interest in German subsidiary Four20 Pharma. This transaction strengthened the company’s position within Europe’s developing medical cannabis industry. However, pricing competition and regulatory uncertainty continue to create challenges across the cannabis sector. Management remains focused on improving operational efficiency and expanding profitable business opportunities. Consequently, Curaleaf’s diversified operations and substantial revenue make CURLF worth monitoring throughout October 2026.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
